<p>Mice in groups of 5 were vaccinated with MVA or MVA-HA at the doses indicated in the legend. Booster vaccinations were administered after 3 weeks, and mice were challenged with 10<sup>6</sup> pfu of influenza rgA/Viet Nam/1203/2004 (H5N1), three weeks after the second vaccination. Mice were weighed for 14 days post challenge. Weight loss as a measure of disease severity is shown in <b>A</b>, and the proportion of surviving animals in the different treatment groups are represented in <b>B</b>.</p
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Groups of mice were immunized with Ad4wt virus to establish pre-existing immunity as described pr...
<p>Groups of mice were vaccinated with a single dose of MVA-HA at doses of 10<sup>2</sup>, 10<sup>3<...
<p>MVA vaccines expressing the HA of VN/1203 (A), of IN5/05 (B), of CE3/06 (C), of TT01/05 (D) and A...
<p>A129 mice (n = 6) were challenged with double the minimum lethal dose of CCHFv 14 days after boos...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>For single dose vaccinations recombinant MVA vaccines expressing the HA of VN/1203 (A), of IN5/05...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p>At day 42, vaccinated mice were challenged intranasally with a lethal dose (100 LD<sub>50</sub>) ...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Groups of mice were immunized with Ad4wt virus to establish pre-existing immunity as described pr...
<p>Groups of mice were vaccinated with a single dose of MVA-HA at doses of 10<sup>2</sup>, 10<sup>3<...
<p>MVA vaccines expressing the HA of VN/1203 (A), of IN5/05 (B), of CE3/06 (C), of TT01/05 (D) and A...
<p>A129 mice (n = 6) were challenged with double the minimum lethal dose of CCHFv 14 days after boos...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>For single dose vaccinations recombinant MVA vaccines expressing the HA of VN/1203 (A), of IN5/05...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p>At day 42, vaccinated mice were challenged intranasally with a lethal dose (100 LD<sub>50</sub>) ...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Groups of mice were immunized with Ad4wt virus to establish pre-existing immunity as described pr...